These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 23709657)
1. Coronary collaterals predict improved survival and allograft function in patients with coronary allograft vasculopathy. Lavine KJ; Sintek M; Novak E; Ewald G; Geltman E; Joseph S; Pfeifer J; Mann DL Circ Heart Fail; 2013 Jul; 6(4):773-84. PubMed ID: 23709657 [TBL] [Abstract][Full Text] [Related]
2. Early aspirin use and the development of cardiac allograft vasculopathy. Kim M; Bergmark BA; Zelniker TA; Mehra MR; Stewart GC; Page DS; Woodcome EL; Smallwood JA; Gabardi S; Givertz MM J Heart Lung Transplant; 2017 Dec; 36(12):1344-1349. PubMed ID: 28781013 [TBL] [Abstract][Full Text] [Related]
3. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients. Clemmensen TS; Eiskjær H; Løgstrup BB; Ilkjær LB; Poulsen SH J Heart Lung Transplant; 2017 May; 36(5):567-576. PubMed ID: 28089194 [TBL] [Abstract][Full Text] [Related]
4. Determinants of coronary flow reserve in heart transplantation: a study performed with contrast-enhanced echocardiography. Osto E; Tona F; Angelini A; Montisci R; Ruscazio M; Vinci A; Tarantini G; Ramondo A; Gambino A; Thiene G; Caforio AL; Gerosa G; Iliceto S J Heart Lung Transplant; 2009 May; 28(5):453-60. PubMed ID: 19416773 [TBL] [Abstract][Full Text] [Related]
5. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Hollenberg SM; Klein LW; Parrillo JE; Scherer M; Burns D; Tamburro P; Oberoi M; Johnson MR; Costanzo MR Circulation; 2001 Dec; 104(25):3091-6. PubMed ID: 11748106 [TBL] [Abstract][Full Text] [Related]
6. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients. Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989 [TBL] [Abstract][Full Text] [Related]
7. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous coronary interventions and bypass surgery in patients with cardiac allograft vasculopathy: a single-center experience. Prada-Delgado O; Estévez-Loureiro R; López-Sainz A; Gargallo-Fernández P; Paniagua-Martín MJ; Marzoa-Rivas R; Barge-Caballero E; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG Transplant Proc; 2012 Nov; 44(9):2657-9. PubMed ID: 23146485 [TBL] [Abstract][Full Text] [Related]
19. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation. Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P; Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients. Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]